简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-01-07 09:30 Avenacy Provides Update on 2025 Strategic Priorities Ahead of 43rd Annual J.P. Morgan Healthcare Conference
2024-12-27 15:08 Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia
2024-12-26 09:07 Kirin’s Electric Salt Spoon Shines At CES Innovation Awards 2025, Earning First-Ever Wins In Digital Health and Accessibility & Age Tech!
2024-12-24 10:35 BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference
2024-12-24 10:11 Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases
2024-12-23 20:05 Ellipses Launches Pioneering Clinical Trial Programme in Middle East
2024-12-23 11:10 SBC Medical Group Co., Ltd. Sells Two Subsidiaries
2024-12-23 10:18 Aster Guardians Global Nursing Award 2025 Worth US$250,000 Now Open for Nominations Worldwide
2024-12-20 10:23 Carestream Secures Crucial Business Partner Agreement in Algeria
2024-12-20 10:09 Kao Corporation: Regarding the Nomination of Director Candidates for Our Company
2024-12-19 16:59 GC Aesthetics® Announces Decade-Long Clinical Evaluation of PERLE™ Breast Implants
2024-12-19 10:23 Novotech Publishes Report on the Global COVID-19 Clinical Trial Landscape, Highlighting Key Trends, Therapeutic Advancements, and Challenges in Drug Development
2024-12-19 10:15 Novotech Releases Report on Global Parkinson’s Disease Clinical Trial Landscape
2024-12-17 16:11 HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial
2024-12-17 10:33 Novotech Named a Fierce CRO Award Winner in the Excellence in Clinical Trial Management and Global Operations Categories
2024-12-17 10:10 Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development
2024-12-16 15:51 Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union
2024-12-16 10:42 Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis
2024-12-16 10:26 BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell
2024-12-14 01:42 Parse Biosciences Launches Evercode Mouse BCR to Support Antibody Engineering and Development for Drug Discovery Applications

Business Wire Weibo

Press Releases

Latest Releases